Apyx Medical Corp

Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segment Successful limited launch of the power liposuction handpiece for the AYON platform to key surgeons in critical geographies; initial commercial shipments in June 2026 Reaffirmed total revenue guidance for FY2026 of $59.0 [...] The post Apyx Medical Corporation Reports Second Quarter 2026 Financial Results appeared first on Apyx Medical.

CLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA. Charlie [...] The post Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference appeared first on Apyx Medical.

CLEARWATER, FL — May 27, 2026 – Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations. Building on last year’s momentum, Apyx Medical has [...] The post Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway appeared first on Apyx Medical.

Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approach CLEARWATER FL, May 21, 2026 —Apyx® Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the publication of new [...] The post New Study Shows Significant Improvement in Cellulite and Skin Laxity With Advanced Minimally Invasive Treatment Utilizing Avéli™ and Renuvion® appeared first on Apyx Medical.

Analysis showed that liposuction followed by helium plasma RF was associated with higher patient-reported satisfaction with abdominal appearance, lower abdominoplasty and revision rates, and comparable complication rates versus conventional liposuction alone. CLEARWATER, FL — May 14, 2026 – Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the [...] The post Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction appeared first on Apyx Medical.

Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON CLEARWATER FL, May 11, 2026 —Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ [...] The post Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™ appeared first on Apyx Medical.

Reported total revenue of $12.5 million in the first quarter of 2026 primarily driven by 36% growth in the Surgical Aesthetics segment Raised total revenue guidance for FY2026 to a range of $59.0 million to $60.0 million Management to host a conference call today at 8:00 a.m. ET CLEARWATER, FL — May 7, 2026 [...] The post Apyx Medical Corporation Reports First Quarter 2026 Financial Results appeared first on Apyx Medical.

CLEARWATER, FL — April 23, 2026 - Apyx® Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the first quarter of fiscal year 2026 will be released before markets open on Thursday, May [...] The post Apyx Medical Corporation To Release First Quarter Of Fiscal Year 2026 Financial Results On May 7, 2026 appeared first on Apyx Medical.

CLEARWATER,Fla., April 1, 2026/PRNewswire/- Apyx® Medical Corporation  (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that Renuvion has been named this year’s NewBeauty Award winner in the "Best Minimally Invasive Skin Tightener"1 category for the second [...] The post Renuvion Wins 2026 NewBeauty Award For “Best Minimally Invasive Skin Tightner” appeared first on Apyx Medical.

Reported record total revenue of $19.2 million in the fourth quarter of 2025 Scaling U.S. commercial launch of AYON Body Contouring System™ (AYON) to meet strong market demand Expect FY2026 total revenue in the range of $57.5 million to $58.5 million Management to host a conference call today at 8:00 a.m. ET CLEARWATER, FL [...] The post Apyx Medical Corporation Reports Fourth Quarter And Full Year 2025 Financial Results appeared first on Apyx Medical.